Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temferon in metastatic renal cell carcinoma
NCT06716853Phase 2Terminated
- Sponsor
- Genenta Science
- Start
- Oct 2024
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Temferon in clear cell renal cell carcinoma (ccRCC), sponsored by Genenta Science. Started Oct 2024; status: terminated.
02
Drugs
Temferon
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT06716853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06716853.